Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder / Ole Köhler-Forsberg en The British Journal of Psychiatry, Año 2019 - Vol. 215 - No. 2 (Agosto)

Público ISBD [artículo]  inThe British Journal of Psychiatry > Año 2019 - Vol. 215 - No. 2 (Agosto) . - pp. 494-501 Título : Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder Tipo de documento: texto impreso Autores: Ole Köhler-Forsberg, Autor ; Erik Roj Larsen, Autor ; Henriette N. Buttenschøn, Autor Fecha de publicación: 2019 Artículo en la página: pp. 494-501 Idioma : Inglés (eng) Palabras clave: Depresión, No respondedores, Efectos secundarios, Antidepresivos, Traspuesta Resumen: For patients with major depressive disorder (MDD) experiencing side-effects or non-response to their first antidepressant, little is known regarding the effect of switching between a tricyclic antidepressant (TCA) and a selective serotonin reuptake inhibitor (SSRI). Link: ./index.php?lvl=notice_display&id=21013 [artículo] Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder [texto impreso] / Ole Köhler-Forsberg, Autor ; Erik Roj Larsen, Autor ; Henriette N. Buttenschøn, Autor . - 2019 . - pp. 494-501. Idioma : Inglés (eng) in The British Journal of Psychiatry > Año 2019 - Vol. 215 - No. 2 (Agosto) . - pp. 494-501 Palabras clave: Depresión, No respondedores, Efectos secundarios, Antidepresivos, Traspuesta Resumen: For patients with major depressive disorder (MDD) experiencing side-effects or non-response to their first antidepressant, little is known regarding the effect of switching between a tricyclic antidepressant (TCA) and a selective serotonin reuptake inhibitor (SSRI). Link: ./index.php?lvl=notice_display&id=21013

The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs / Ole Köhler-Forsberg en European Neuropsychopharmacology, Año 2020 - Vol.32 (Marzo)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2020 - Vol.32 (Marzo) . - pp. 120-130 Título : The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs : A propensity score matched cohort study Tipo de documento: texto impreso Autores: Ole Köhler-Forsberg, Autor ; Liselotte Vogdrup Petersen, Autor ; Berk, Michael, Autor Fecha de publicación: 2021 Artículo en la página: pp. 120-130 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Depresión, Inflamación, ISRS, Renina-angiotensina, Antidepresivo Resumen: Drugs acting on the renin-angiotensin system (RAS) may have beneficial effects on mental health. We investigated whether use of drugs acting on the RAS, as add-on to selective serotonin reuptake inhibitors (SSRIs), was associated with a reduced risk of psychiatric hospital contacts. Link: ./index.php?lvl=notice_display&id=26341 [artículo] The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs : A propensity score matched cohort study [texto impreso] / Ole Köhler-Forsberg, Autor ; Liselotte Vogdrup Petersen, Autor ; Berk, Michael, Autor . - 2021 . - pp. 120-130. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2020 - Vol.32 (Marzo) . - pp. 120-130 Palabras clave: Depresión, Inflamación, ISRS, Renina-angiotensina, Antidepresivo Resumen: Drugs acting on the renin-angiotensin system (RAS) may have beneficial effects on mental health. We investigated whether use of drugs acting on the RAS, as add-on to selective serotonin reuptake inhibitors (SSRIs), was associated with a reduced risk of psychiatric hospital contacts. Link: ./index.php?lvl=notice_display&id=26341

---

1 (1 - 2 / 2)